Cargando…

Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department

We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January...

Descripción completa

Detalles Bibliográficos
Autores principales: Blache, Guillaume, El Hajj, Houssein, Jauffret, Camille, Houvenaeghel, Gilles, Sabiani, Laura, Barrou, Julien, Masquin, Isabelle, Le Saout, Jérémy, Mokart, Djamel, Faucher, Marion, Lambaudie, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097084/
https://www.ncbi.nlm.nih.gov/pubmed/33968755
http://dx.doi.org/10.3389/fonc.2021.653009
_version_ 1783688281459785728
author Blache, Guillaume
El Hajj, Houssein
Jauffret, Camille
Houvenaeghel, Gilles
Sabiani, Laura
Barrou, Julien
Masquin, Isabelle
Le Saout, Jérémy
Mokart, Djamel
Faucher, Marion
Lambaudie, Eric
author_facet Blache, Guillaume
El Hajj, Houssein
Jauffret, Camille
Houvenaeghel, Gilles
Sabiani, Laura
Barrou, Julien
Masquin, Isabelle
Le Saout, Jérémy
Mokart, Djamel
Faucher, Marion
Lambaudie, Eric
author_sort Blache, Guillaume
collection PubMed
description We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the COVID-19 pandemic on surgical activity. The secondary objectives were to analyze the surgical and the oncologic outcomes. We compared the surgical activity during the 8 weeks after the national lockdown (85 procedures) to the surgical activity in the 8 weeks preceding the lockdown (127 procedures). We observed a 33% decrease in activity between the two periods. The clinical and epidemiologic characteristics were similar between the two periods. There were no differences between the surgical approaches (p = 0.592), the surgical complexity (p = 0.323), the length of stay (p = 0.85), and even for the complex procedure (p = 0.96) and the perioperative (p = 0.791) and postoperative complication rates (p = 0.102). We observed a significant decrease in the time of return to intended oncological treatment (RIOT) during the lockdown period with an average of 31.9 days compared to 46.9 days in the pre-lockdown period (p = 0.003). During the COVID-19 pandemic, “care as usual” represents an acceptable strategy without impairing the oncologic outcome in a Comprehensive Cancer Center with a patient-centered clinical pathway for gynecologic oncologic surgical patients.
format Online
Article
Text
id pubmed-8097084
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80970842021-05-06 Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department Blache, Guillaume El Hajj, Houssein Jauffret, Camille Houvenaeghel, Gilles Sabiani, Laura Barrou, Julien Masquin, Isabelle Le Saout, Jérémy Mokart, Djamel Faucher, Marion Lambaudie, Eric Front Oncol Oncology We describe and analyze a “care as usual” strategy of a French Comprehensive Cancer Center during the COVID-19 pandemic to manage surgical patients with gynecological cancer. We conducted a retrospective analysis evaluating the surgical activity in our gynecologic oncology department between January 21 and May 12, 2020. We compared the surgical activity and surgical and oncologic outcomes during the pre-lockdown period and the pandemic period. The main objective was to evaluate the impact of the COVID-19 pandemic on surgical activity. The secondary objectives were to analyze the surgical and the oncologic outcomes. We compared the surgical activity during the 8 weeks after the national lockdown (85 procedures) to the surgical activity in the 8 weeks preceding the lockdown (127 procedures). We observed a 33% decrease in activity between the two periods. The clinical and epidemiologic characteristics were similar between the two periods. There were no differences between the surgical approaches (p = 0.592), the surgical complexity (p = 0.323), the length of stay (p = 0.85), and even for the complex procedure (p = 0.96) and the perioperative (p = 0.791) and postoperative complication rates (p = 0.102). We observed a significant decrease in the time of return to intended oncological treatment (RIOT) during the lockdown period with an average of 31.9 days compared to 46.9 days in the pre-lockdown period (p = 0.003). During the COVID-19 pandemic, “care as usual” represents an acceptable strategy without impairing the oncologic outcome in a Comprehensive Cancer Center with a patient-centered clinical pathway for gynecologic oncologic surgical patients. Frontiers Media S.A. 2021-04-21 /pmc/articles/PMC8097084/ /pubmed/33968755 http://dx.doi.org/10.3389/fonc.2021.653009 Text en Copyright © 2021 Blache, El Hajj, Jauffret, Houvenaeghel, Sabiani, Barrou, Masquin, Le Saout, Mokart, Faucher and Lambaudie. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Blache, Guillaume
El Hajj, Houssein
Jauffret, Camille
Houvenaeghel, Gilles
Sabiani, Laura
Barrou, Julien
Masquin, Isabelle
Le Saout, Jérémy
Mokart, Djamel
Faucher, Marion
Lambaudie, Eric
Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title_full Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title_fullStr Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title_full_unstemmed Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title_short Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department
title_sort care as usual: an acceptable strategy to apply during the covid-19 pandemic in a french tertiary gynecologic oncology department
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097084/
https://www.ncbi.nlm.nih.gov/pubmed/33968755
http://dx.doi.org/10.3389/fonc.2021.653009
work_keys_str_mv AT blacheguillaume careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT elhajjhoussein careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT jauffretcamille careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT houvenaeghelgilles careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT sabianilaura careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT barroujulien careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT masquinisabelle careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT lesaoutjeremy careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT mokartdjamel careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT fauchermarion careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment
AT lambaudieeric careasusualanacceptablestrategytoapplyduringthecovid19pandemicinafrenchtertiarygynecologiconcologydepartment